Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 22, Issue 9, Pages 991-993
Publisher
Springer Nature
Online
2016-08-08
DOI
10.1038/nm.4148
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE
- (2015) Jens Y Humrich et al. ANNALS OF THE RHEUMATIC DISEASES
- Circulating Follicular Helper-Like T Cells in Systemic Lupus Erythematosus: Association With Disease Activity
- (2015) Jin-Young Choi et al. Arthritis & Rheumatology
- Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys
- (2014) J. C. Crispin et al. JOURNAL OF IMMUNOLOGY
- Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
- (2014) Emeline Castela et al. JAMA Dermatology
- Circulating Precursor CCR7loPD-1hi CXCR5+ CD4+ T Cells Indicate Tfh Cell Activity and Promote Antibody Responses upon Antigen Reexposure
- (2013) Jing He et al. IMMUNITY
- Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
- (2013) K.-i. Matsuoka et al. Science Translational Medicine
- Clinical associations of serum interleukin-17 in systemic lupus erythematosus
- (2013) Fabien B Vincent et al. ARTHRITIS RESEARCH & THERAPY
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Interleukin-2 Inhibits Germinal Center Formation by Limiting T Follicular Helper Cell Differentiation
- (2012) André Ballesteros-Tato et al. IMMUNITY
- Taming lupus—a new understanding of pathogenesis is leading to clinical advances
- (2012) Zheng Liu et al. NATURE MEDICINE
- Effector T-cell subsets in systemic lupus erythematosus
- (2011) Min S. Shin et al. CURRENT OPINION IN RHEUMATOLOGY
- Systemic Lupus Erythematosus
- (2011) George C. Tsokos NEW ENGLAND JOURNAL OF MEDICINE
- Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
- (2011) David Saadoun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- The IL-2 Defect in Systemic Lupus Erythematosus Disease Has an Expansive Effect on Host Immunity
- (2010) Linda A. Lieberman et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- T cells as therapeutic targets in SLE
- (2010) José C. Crispín et al. Nature Reviews Rheumatology
- Novel evidence-based systemic lupus erythematosus responder index
- (2009) Richard A. Furie et al. ARTHRITIS AND RHEUMATISM
- Th17 and natural Treg cell population dynamics in systemic lupus erythematosus
- (2009) Ji Yang et al. ARTHRITIS AND RHEUMATISM
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started